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Abstract
Background: Dysregulated endocytosis of membrane proteins contributes significantly to several hallmarks of cancer.
Basigin can enhance cancer progression, but its precise mechanism remains unclear. CD98 promotes cell spreading and
tumorigenicity by triggering integrin clustering and enhancing cell adhesion to the extracellular matrix. The endocytosis
and recyle of basigin and CD98 might play critical roles in cancer.
Methods: The role of CD98 was confirmed in liver cancer cells by cell spreading in vitro and tumorigenicity by nude mice
xenograft tumor assay in vivo; membrane expression of basigin and CD98 in SMMC-7721 was measured by FCAS;
pull down and SPR analysis were uses to reveal the direct association between basigin and CD98; DsRed1 tagged
CD98 was blocked in the cytoplasm in K7721 (whose basigin was knockn out) and had a well colocalization with
ER and Rab5a positive recycling endosomes under co-focal; finally, by FRET imaging and FCAS we observed the
internalization of basigin and CD98 was flotillin-1-regulated, and their recycle at early steps was Arf6-mediated.
Results: Basigin and CD98 were highly expressed and co-localized on the human hepatocellular carcinoma (HCC)
cell membrane; basigin can directly bind to CD98, mediating CD98 redistribution on the HCC cell membrane and
activating the downstream integrin signaling pathway. Internalization of basigin and CD98 was flotillin-1 regulated the
and their recycling was mediated by Arf6. This recycling process for basigin and CD98 promotes cell spreading and
tumor growth in liver cancer xenografts.
Conclusion: Basigin, as a redistribution chaperone of CD98, plays a critical role in promoting cell spreading and the
progression of hepatocellular carcinoma.
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Background
The aberrant distribution of membrane proteins, includ-
ing immune adhesion molecules, conjunction proteins
and many RTKs (receptor tyrosine kinases), can create
markedly altered tissue polarity and instigate motile phe-
notypes and cancerous cell behavior in normal cells [1–3].
Dysregulated endocytosis contributes significantly to sev-
eral hallmarks of cancer [4]. Membrane proteins could be
internalized through CME (clathrin-mediated endocytosis)
or CIE (clathrin-independent endocytosis). Clathrin,
adaptor proteins, dynamin and other GTPases participate
in and regulate the process of CME [5]. Caveolin, flotillin-
1, RhoA and Arf6 were reported to mediate different types
of CIE [6, 7]. After endocytosis, the internalized proteins
(both CME and CIE protein) first converge into Rab5a-
positive endosomes. Then, a series of sorting events affect
the fate of the internalized proteins, resulting in either
degradation in the lysosomes or recycling back to the
plasma membrane [8–11]. The recycling endosomes con-
trol the amplitude and duration of oncogenic signaling
from cancerous cells by regulating receptor recycling and
redistribution [4, 12]. Although the basic features of the
endocytic process had been established more than two
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decades ago, researches on how the vesicles are recycled
to mediate the distribution of tumor drivers, especially the
CIE proteins, are rare.
HCC is a common malignancy worldwide, and to de-
velop targeted diagnostic tools and novel therapies efforts
have been tried to understand the molecular basis of HCC
[13–15]. Basigin, also known as CD147 or EMMPRIN
(extracellular matrix metalloproteinase inducer), is grad-
ually being recognized as a cancer-associated biomarker,
and significant clinical therapeutic progress has been made
using anti-basigin monoclonal antibodies that target HCC
[16, 17]. Previously, we identified the downstream effectors
of basigin, such as PI3K, TGF-β and MMPs, which can
promote liver cancer phenotypes and behavior [18–20],
but the precise mechanism remains obscure. Identifying
the binding partners of basigin could help elucidate how
basigin functions in cancer progression. CD98 was
reported to be associated with basigin [21, 22], contribut-
ing to tumor growth in a variety of cancers with a high
expression level of this protein [23–25]. CD98 can pro-
mote the activation of β1 and β3 integrins by FAK phos-
phorylation, which eventually promotes cancer cell
survival, proliferation and migration [26, 27]. As these two
important tumor-associated membrane proteins are both
internalized through CIE [28], further clarifying how basi-
gin and CD98 participate in and undergo vesicle recycling
is critical to understand the behaviors and malignant phe-
notypes of cancer cells.
In this work, we confirmed that the redistribution of
CD98 is mediated by direct interaction with basigin and
that they promote the malignant phenotypes of HCC
cells through flotillin-1-mediated internalization and the
early steps of Arf6-mediated recycling.
Materials and methods
Cell culture and reagents
Human SMMC-7721 HCC cells (Institute of Biochemis-
try and Cell Biology, Academic Sinica, Shanghai, China)
were cultured in RPMI1640 (Gibco, New York, USA)
with 10 % fetal bovine serum, 2 mM glutamine, 100 U/ml
penicillin, and 100 μg/ml streptomycin in 5 % CO2 atmos-
phere at 37 °C. K7721 cells (developed from SMMC-7721
cells by a zinc-finger nuclease-targeted knockout of the
basigin gene [29]) were cultured in the same conditions.
The human liver carcinoma cells HepG2 and Huh7 were
obtained from ATCC were cultured in DMEM medium
(Gibco, New York, USA) containing 10 % fetal bovine
serum.
The CD98 antibody (for immunofluorescence) was pur-
chased from Abcam (ab23495), rabbit polyclonal anti-
bodies to CD98 (for western blot) were from Wuhan Co.,
China (15193-1-AP), and rabbit polyclonal antibodies to
CD147 (sc-13976) and Flotillin-1(sc-74566) were from
Santa Cruz Biotechnology. Antibodies to β1 integrin and
activated β1 integrin were from Abcam (ab3167) and Milli-
pore Co. (mab2079Z), respectively. Antibodies to CD98-PE
(556077) and CD147-FITC (555962) for flow cytometry
were from BD Bioscience. Rabbit polyclonal antibodies to
Akt and p-Akt were from CST (9272S) and Abcam
(ab81283), respectively. Antibodies to basigin (HAb18,
IgG1) and α-tubulin were developed in our laboratory.
Plasmids
The following plasmids were used: pET32a(+) (Invitrogen,
Carlsbad, CA, USA), peGFP-N1 (Clontech, Mountain View,
CA, US), pcDNA3.1 (Invitrogen, Carlsbad, CA, USA),
pcDNA3.1-CD147 (NM_198589), pdsRed1-N1-CD147
(CD147-dsRed1) and pCMV5-CD98 (NM_002394.5). The
CD98 sequence coding for the CD98-ED (residues
111–530 of CD98) was cloned into the pET32a(+)
plasmid with Nde I/Xho I. Sequences encoding eGFP
were inserted into the signal peptide and coding sequense
of CD147 by overlapping PCR (Polymerase Chain Reac-
tion) and then cloned into peGFP-N1 with Hind III/Not I
to create peGFP-CD147(N). Then the intracellular or
extracellular domain of CD147 were deleted to generate
peGFP-CD147(N)-out and peGFP-CD147(N)-in, respect-
ively. Similarly, the coding sequences of CD98, along with
DsRed1 from pDsRed1-N1, were cloned into pcDNA3.1
with Nhe I/Xho I to generate pcDNA3.1-dsRED1-CD98.
Wild-type (accession no. NM_001663.3) and mutated
Arf6 (Q67L) were cloned into pcDNA3.1 with Nhe I/Xho
I to generate pcDNA3.1-Arf6 and pcDNA3.1-Arf6Q67L
respectively. Flotillin-1(NM_005803.2) were cloned and
inserted into peGFP-N1 to create Flotillin-1-eGFP.
Validated expression plasmids for pLKO–SLC3A2(CD98)
shRNA (CCGGCGAGAAGAATGGTCTGGTGAACTCG
AGTTCACCAGACCATTCTTCTCGTTTTTG) and pL
KO–control shRNA plasmid were purchased from Sigma.
EGFP-Rab5AQ79L was a gift from Dr. Qing Zhong
(University of California, Berkeley) and shared through
Addgene (Plasmid 28046). GFP-Rab11 was from Dr.
Richard Pagano (Mayo Foundation for Medical Education
and Research) via Addgene (Plasmid 12674). The Quik-
Change Lightning Multi Site-Directed Mutagenesis Kit
was from Stratagene, Santa Clara, CA, USA. The complete
sequence of the above constructs can be obtained upon
request.
RNA interference and transfection
Small interfering RNA (siRNA) sequences for CD147-
siRNA: GTACAAGATCACTGACTCT and CD98-siRNA:
GAGCCGAGAAGAAUGGUCUGGUGAA were designed
and synthesized by Shanghai GenePharma (Shanghai,
China). RNA oligonucleotides to the conserved regions in
human flotillin-1 (UGAGGCCAUGGUGGUCUCCdTdT
and CACACUGACCCUCAAUGUCdTdT) were prepared
as duplexes with overhanging dTs (GenePharma, Shanghai,
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China) [6]. The cells were transfected with the siRNAs or
plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA, US). siGAPDH (5’-GUA UGA CAA CAG CCU CAA
GTT-3’) and snc-RNA (5’-UUC UCC GAA CGU GUC
ACG UTT-3’) were used as positive and negative controls,
respectively, under similar conditions.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted using an Omega R6934-01
Total RNA Kit. cDNA was synthesized using Prime
Script RT Reagent (Takara, DRR037A). qPCR was per-
formed on a LightCycler 2.0 using SYBR® Premix Ex
Taq™ (Takara, DRR081A). The results were calculated
using the 2-△△Ct method[30]. The following primers were
used in this study: GAPDH: Forward 5’-GCACCGTCAA
GGCTGAGAAC-3’, Reverse 5’-TGGTGAAGACGCCAG
TGGA-3’; CD98: Forward 5’-GGGTTCCAGGTTCGGG
ACATA-3’, Reverse 5’-GGAGGAGTTAGTCCCCGCAA
T-3’; CD147: Forward 5’-ACTCCTCACCTGCTCCT
TGA-3’, Reverse 5’-GCCTCCATGTTCAGGTTCTC-3’.
Western blotting and pull-down assay
Cell extracts (30 μg) were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS–PAGE)
and transferred onto a polyvinylidene difluoride (PVDF)
microporous membrane (Millipore, Boston, MA, USA).
The membrane was incubated with primary antibodies
against CD147, CD98, integrin, and α-tubulin, accord-
ing to the manufacturer’s instructions. Horseradish
peroxidase-conjugated secondary antibodies (1:5000;
Santa Cruz Biotechnology, Santa Cruz, CA) were ap-
plied to the membrane and detected using enhanced
chemiluminescence reagents (Pierce, Rockford, IL). For
the pull-down assay, 10 μg of the HAb18 mAb was first
immobilized onto AminoLink Plus Coupling Resin
(Pierce kit, Lot: 26149). Then, the bait (CD147-ED) and
prey proteins (different amount of CD98-ED) were
mixed. The protein mixture and controls (CD98-ED only)
were then added to the appropriate resin and incubated.
After the resin was washed three times with PBS, the
eluted samples were subjected to western blotting.
Cell-spreading assay
Five thousand cells per cm2 were plated onto 1 % Matrigel
(BD Bioscience, Franklin Lakes, NJ, USA)-coated glass
coverslips. At different time points, the coverslips were
removed, and the cells were fixed in PBS with 4 % formal-
dehyde for 10 min, stained with rhodamine-phalloidin
(R415, Invitrogen, USA), and viewed using phase micros-
copy (Olympus, Tokyo, Japan) [31]. The cells were
assessed with ImageJ software (1.47v, National Institutes
of Health). The results are the average percent from three
independent experiments ± SEM.
Surface plasmon resonance (SPR) assay
SPR measurements were performed using the ProteOn
XPR36 protein interaction array system (Bio-Rad
Laboratories) according to a standard procedure. After
CD147-ED was immobilized onto the activated GLC
sensor chip surface, six different concentrations of CD98-
ED (0, 3, 1.5, 0.75, 0.375, 0.1875 μM) were simultaneously
injected into the chip for association (180 s) and dissoci-
ation (600 s). The binding kinetics was analyzed with Pro-
teOn Manager Version 2.0 software (BioRad).
Image analysis
Immunofluorescence
Cells were cultured in a 24-well plate that had been pre-
coated with Matrigel for 3 h. The cells were then fixed
with 4 % formaldehyde, permeabilized with 0.2 % Triton
X-100 and blocked with 1 % BSA (Beyotime, Shanghai,
China) in PBS for 30 min. The cells were incubated with
a primary antibody and Dylight488 or Dylight594 labeled
secondary antibodies (Life Technologies). The nuclei
were counterstained using Vectashield with DAPI (Vector
laboratories, Burlingame, CA, USA). The ER was labeled
with ER-Tracker™ (E34251, Invitrogen, USA). The samples
were visualized with a confocal microscope using Nikon
NIS-Elements software (Nikon, Tokyo, Japan).
Co-localization analysis
Co-localization data was evaluated in original images,
obtained by confocal microscopy. Analysis was performed
with Nikon NIS-Elements software (Nikon, Tokyo, Japan).
FRET measurements
FRET measurements were performed as previously
described [32].
Flow cytometry analysis
The cells were digested with trypsin, washed twice with
PBS and suspended in PBS containing 0.02 % (w/v)
sodium azide and 0.1 % (w/v) BSA. After incubation
with the primary antibody (HAb 18, CD98, β1 integrin
or β1 integrin-A) for 1 h on ice, the cells were washed 3
times and incubated with Dylight488-conjugated sec-
ondary antibodies for 45 min at room temperature in
the dark and washed twice. Or detached cells were incu-
bated directly with labled antibody (CD147-FITC and
CD98-PE) for 1 h on ice and washed twice. The cells
were analyzed using a FACS Calibur flow cytometer
(Becton Dickinson, San Jose, CA).
In vivo assessment of tumorigenicity
Female BALB/c nude mice (6-weeks-old) were selected
from the Laboratory Animal Research Center of FMMU,
compliant with the regulations. Animal welfare and ex-
perimental procedures were performed according to the
Wu et al. Journal of Experimental & Clinical Cancer Research  (2015) 34:110 Page 3 of 14
Fig. 1 (See legend on next page.)
Wu et al. Journal of Experimental & Clinical Cancer Research  (2015) 34:110 Page 4 of 14
NIH Guide for the Care and Use of Laboratory Animals.
SMMC7721shNC or SMMC7721shCD98 cells (5 × 105
cells) in 0.2 mL PBS were injected subcutaneously on both
sides of the lumbar region. All the mice were observed and
examined daily for the formation of nodules at the site of
injection. Tumor size was calculated by measuring the di-
mensions of the tumor mass (average of the two right-angle
diameters), and volume was calculated as (4π/3) × (size/2)3.
The period of observation was one month, after which all
mice were euthanized and autopsied. The excised tumors
were then weighed.
Statistical analysis
All statistical tests were performed using SPSS 16 (Chicago,
IL, USA). The data are expressed as the mean ± SEM of at
least three independent experiments. Comparisons were
made using Student’s t-test or ANOVA, and a significant
difference was defined as P < 0.05.
Results
CD98 knockdown inhibits SMMC-7721 cell spreading and
tumorigenicity in vitro and in vivo
To investigate the role of CD98 in HCC cells, a stable
CD98 knockdown cell line, SMMC-7721shCD98, was
constructed using a shRNA that targeted CD98. As
shown in Fig. 1a and 1b, the expression of CD98 was
significantly inhibited in SMMC-7721shCD98 cells as
analysed by immunofluorescence and FCAS, respect-
ively. SMMC-7721shCD98 cells showed a dramatic re-
duction in the percentage of spreading cells (43.2 ± 5 %)
on Matrigel-coated glass coverslips compared to control
cells (78.6 ± 6 %) after 2 h (Fig. 1c). To observe the
tumorigenicity in vivo, 5 × 105 control or SMMC-
7721shCD98 cells were injected into both sides of nude
mice. As shown in Fig. 1d, all of the mice in the control
group formed nodules at the 8th day. However, only one
mouse in the SMMC7721shCD98 group formed nodules
at the 11th day. Furthermore, the tumors from the
control group grew dramatically, while the body weight
of the two groups showed no apparent change. Finally,
all of the mice were euthanized, and the tumors were
excised and weighed. As shown in Fig. 1d, the weight of
the excised tumors in the control group was significantly
heavier than those in the SMMC7721shCD98 group
(P < 0.01). The above results indicated that CD98 can
promote cell spreading and tumorigenicity in HCC cells.
Basigin mediates the membrane localization of CD98 in
HCC cells
The membrane localization of CD98 plays important
roles in inducing the malignant phenotypes of cancer
cells and its membrane expression was decreased
(Fig. 1a and 1b). Here, we found that the activation of
β1 integrin and p-Akt were significantly decreased in
SMMC7721shCD98 cells compared to the control group
(Fig. 2a). Besides CD98 overexpression activated β1 integ-
rin, we also found overexpression of basigin could activate
β1 integrin (Fig. 2b and Additional file 1: Supplementary
material Fig. S1). Interestingly, when basigin was knocked
down, the FACS results showed reduced CD98 membrane
localization (Fig. 2c and Fig. 2d, upper pannel), while
CD98 at mRNA level (Fig. 2e) or total protein level was
not influenced (Fig. 2f). Additionally, cells with ectopic
expression of basigin showed a high level of CD98 at the
cell membrane (Fig. 2c and Fig. 2d,lower pannel) without
influencing mRNA (Fig. 2e) total protein (Fig. 2f ).
However, when CD98 was knocked down with siRNA,
basigin was increased at mRNA level and membrane
level (Additional file 1: Supplementary material Fig. S2).
These results indicated that the basigin-mediated mem-
brane localization of CD98 was responsible for the acti-
vation of downstream integrin-PI3K-Akt signaling,
promoting the malignant phenotype of HCC cells.
CD98 directly interacts with basigin in HCC cells
To explore how basigin mediates the membrane
localization of CD98 in HCC cells, the interaction of these
two molecules was analyzed. The immunofluorescence
staining results showed that there was a significant colocali-
zation of CD147 with CD98 in HCC cells (SMMC-7721,
(See figure on previous page.)
Fig. 1 CD98 is involved in the spreading and tumorigenicity of SMMC-7721 cells in vitro and in vivo. a SMMC-7721 cells were transfected with
pLKO–SLC3A2(CD98) shRNA (SMMC-7721shCD98) or pLKO–control shRNA plasmid (control) and selected with 5 μg/ml of puromycin for two
weeks. The cells (5 × 104 cells) were grown on coverslips for 24 h, fixed and stained with Dylight594-conjugated goat-anti-mouse antibodies
(CD98, Red). Representative CD98 immunofluorescence of control and SMMC-7721shCD98 cells are shown in (a) DAPI (blue staining). Bar, 10 μm. b FCAS
analysis of membrane CD98 in control and SMMC-7721shCD98 cells. Growing cells were harvested and incubated with fluorescence-labeled antibody
against CD98 (PE) for 1 h. Next, the labeled cells were analyzed using flow cytometry. Mean fluorescence intensities (MFI) of each group
was indicated beside the histograms.The data shown are representative of three individual experiments. c SMMC-7721 cell spreading assay
in vitro. Control or SMMC-7721shCD98 cells (5× 104 cells) were cultured on coverslips with 1 % matrigel for 2 h, and then the cells were
fixed and stained with rhodamine-phalloidin for visualization (right) and scoring (left). The percentage of spread cells was determined by scoring >100
cells. The data are the mean of the “% of spreaded cells” from three independent experiments ± SED. Bar, 10 μm. ** P < 0.01. d Tumorigenicity of cells
transplanted into nude mice. Control or SMMC-7721shCD98 cells (5 × 105 cells per site) were injected into both sides of 6-weeks-old female nude mice.
Tumor volumes were determined at various time points (see Materials and Methods for details). On day 18, the primary tumors were harvested and
weighed (e). *** P < 0.001
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HepG2 and Huh7; Fig. 3a). The immunoprecipitation re-
sults in our previous report showed that CD147 and CD98
could form a complex in vitro [21]. To determine whether
the two molecules directly interact, we then expressed the
extracellular domain of basigin (CD147-ED) [33] and the
extracellular domain of CD98 (CD98-ED) in Escherichia
coli BL21 (DE3) and purified the proteins (Additional file 2:
Supplementary material Fig. S3) to further explore their
interaction. As shown in Fig. 3b, CD147-ED could pull
down CD98-ED in a concentration-dependent manner.
Furthermore, surface plasmon resonance (SPR) assays
obtained a similar result, in which the SPR data fit well to a
one-shot kinetic binding model (chi-squared value 3.73)
and revealed an average binding affinity (dissociation equi-
librium constant, KD) of approximately 0.187 μM (see table
in Fig. 3c). These results were also consistent with our
previous report [21] and indicated that basigin directly
interacted with CD98.
Basigin mediates the membrane redistribution of CD98 in
HCC cells
As mentioned above, basigin and CD98 co-localize on
the membrane of HCC cells and interact directly in
vitro. We then overexpressed dsRED1-CD98 in K7721
cells (Additional file 2: Supplementary material Fig. S3)
to observe the distribution of CD98 in the absent of
basigin. The confocal result showed that dsRED1-CD98
localized to the membrane in the SMMC-7721 cells,
while most of the red fluorescent signal was retained in
the cytoplasm of the K7721 cells (Fig. 4a and b). Interest-
ingly, we found that dsRED1-CD98 had a well colocaliza-
tion with the ER (Fig. 4c, upper panel) and Rab5a-positive
recycling endosomes in K7721 cells (Fig. 4c, middle panel;
GFP-Rab11 in the lower panel is irrelevant). Rab5a endo-
somes are where internalized membrane proteins (both
CIE and CME proteins) converge, and here, we used
GFP-Rab5aQ79L to indicate the distribution of this kind of
endosome [34–36]. Different portions of basigin fused with
eGFP were then co-transfected with dsRED1-CD98 into
K7721 cells. The immunofluorescence staining (Fig. 4d,
upper and middle panel) showed that both eGFP-N1-
CD147(N) and eGFP-N1-CD147(N)-out transfected cells
displayed a strong red fluorescent signal at the membrane
of the K7721 cells. However, eGFP-N1-CD147(N)-in trans-
fected cells showed red fluorescent signal in the cytoplasm
(Fig. 4d, lower panel). The above results indicate that the
membrane distribution of CD98 is correlated with the
expression of basigin, particularly the extracellular domain,
and that basigin may act as a chaperone to promote the
membrane localization of CD98.
Basigin facilitates the early steps of the endocytic recycling
process of CD98
As CD98 was detained in the Rab5a-positive recycling
endosomes in the absence of basigin, we examined
whether the proteins would be transported together in
recycling endosomes. Here, we showed that both basigin
and CD98 had a FERT effect with flotillin-1 (Fig. 5a).
After knocking down flotillin-1 in SMMC-7721 cells, the
membrane localization of basigin and CD98 both
increased, as shown in Fig. 5b, while the total amount of
basigin and CD98 protein did not change. This result sug-
gests that flotillin-1 may participate in the internalization
of basigin and CD98 in SMMC-7721 cells.
After co-expressing GFP-CD147 and Arf6Q67L
(constitutively activated form) in SMMC-7721 cells,
both basigin and CD98 accumulated in the vacuolar mem-
branes (Fig. 5d and e, cell d, marked with an arrow).
Therefore, the expression of Arf6Q67L promoted CIE
internalization of both basigin and CD98. Then, the endo-
somes fused together, causing the accumulation of the
cargo proteins in vacuolar-type structures. As to CD98
retaining in the Rab5a-positive recycling endosomes in
K7721, the internalized endosomes containing CD98 may
have fused with the Rab5a early endosomes, thus blocking
further recycling. Together, these results demonstrated that
both flotillin-1 and Arf6 influenced the internalization and
endocytosis of basigin and CD98 and that basigin may
facilitate the early steps of CD98 recycling.
Discussion
Vesicle recycling plays a critical role in the process of
tumor progression through signal transduction and
membrane protein redistribution [1, 2]. In this work, we
first reported that basigin, a CIE protein, mediates the
redistribution and translocation of CD98 to activate β1
(See figure on previous page.)
Fig. 2 Cell membrane localization of CD98 is mediated by basigin in HCC cells. a Changes in the molecular expression patterns were detected in
control and SMMC-7721shCD98 cells. Control or SMMC-7721shCD98 cell lysates (30 μg) were subjected to western blot to analyze the expression
of basigin, β1-integrin-A, β1-integrin, p-Akt, Akt and α-tubulin (reference control). b The membrane expression of β1-integrin-A and β1-integrin
were analyzed using flow cytometry after overexpression of basigin or CD98, respectively. Black histograms (Blank) represent staining with isotype
control. c The membrane localization of CD98 after basigin was knockdown or overexpressed. Mean fluorescence intensities (MFI) of each group
was indicated beside the histograms. d MFI ratio of transfected cells and control cells. The results shown are representative of three independent
experiments. ** P< 0.01. eThe mRNA and protein expression of CD98 in SMMC7721 cells with basigin knockdown or overexpression. After SMMC-7721 cells
were transfected with basigin siRNA or pcDNA-3.1-CD147 for 36 h, the mRNA levels of basigin and CD98 were analyzed by RT-PCR. The results shown are
representative of three independent experiments. ** P< 0.01 (f) Analysis of the total protein levels of basigin and CD98 by western blotting. The samples
were first transfected as described in part (E) and then subjected to western blotting
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integrin and its downstream signaling, which is related
to tumor spreading and tumorigenicity in HCC cells.
Through direct association with CD98, basigin first facil-
itated CD98 membrane localization. Second, the two
proteins may be transported together efficiently via the
fast vesicle recycling pathway. This recycling process
avoids the slow recycling pathway through the Rab11-
positive endosomes or the default pathway for protein
degradation [37] (Fig. 6).
Previously, CD98 was reported to directly interact with
and activate β1 integrin and thereby activate compo-
nents of the downstream signaling pathway, such as
FAK, Rac, and Akt [24, 26, 27, 38, 39]. CD98 overexpres-
sion is detected in a variety of cancers and is associated
with poor clinical prognosis [23, 25]. However, the role
of CD98 has not been investigated in liver cancer. In this
study, we constructed a stable CD98 knockdown cell
line, SMMC-7721shCD98, and found that cell spreading
and tumorigenicity were inhibited in vitro and in vivo.
CD98 regulates cell growth and proliferation by being
the heavy chain of amino acid transporters LAT1 and
LAT2, which are amino acid exchangers and can import
essential amino acids (EAA) [40, 41]. CD98 would be
detrimental for tumor growth, but at the preliminary
stage of tumorigenicity, the role of its cell spreading and
adhering to the extracellular matrix is more important.
These phenomena observed in our results agree with a
defect in integrin signaling. It was reported that β1
integrins are involved in various biological functions,
such as cell growth, spreading, migration, metastasis,
and immunologic and inflammatory responses. β1 integ-
rins also play an important role in cancer cell signaling,
including Rho-GTPases and downstream kinases [42, 43].
In this study, CD98 knockdown significantly inhibited β1
integrin activation and downstream FAK-PI3K signaling,
along with a decreased level of p-Akt. Activation of AKT1
(p-Akt)was associated with poor prognosis in cancers like
esophageal squamous cell carcinoma [44]. Similarly,
ectopic expression of CD98 could activate β1 integrins.
Basigin is a transmembrane glycoprotein and is ubi-
quitously expressed in cancer tissues, with a significantly
higher overall positive rate of 67.76 % than that observed
in sarcoma (27.34 %) and normal tissue (5.18 %) [17]. The
increased basigin levels were positively correlated with
cancer metastasis and progression [45]. As an upstream
activator of MMPs, most findings showed that the un-
regulated basigin increased the secretion and activation of
MMPs to promote the invasion and metastasis of cancer
cells [20, 46]. Basigin could also activate β1 integrins, but
a previous study stressed that basigin binds to the metal
ion-dependent adhesion site (MIDAS) motifs of β1 integ-
rins to modulate the malignant properties of hepatoma
cells [47]. Basigin was previously shown to interact with
CD98, but the precise role of basigin in tumor progres-
sion is not clear. Here, we showed that basigin could
contribute to the progression of liver cancer by redis-
tributing CD98 to the membrane and activating down-
stream β1 integrin signaling. Previous studies found
that basigin and CD98 formed protein complex by immu-
noprecipitation in vitro, but how they interacted as a com-
plex was not known [21, 22]. Here, we confirmed the
direct association of basigin and CD98 and hypothesized
that this interaction may participate in the tumorigenicity
of HCC cells.
Previous studies have shown that basigin could be a
chaperone for MCT1-4 maturation in the ER and its
translocation to the membrane [48, 49]. In this study,
CD98 was retained in the ER in the absence of basigin,
indicating that basigin may function as a chaperone for
CD98, or at least the complex containing basigin, MCTs,
CD98 and LATs assemble in ER [50]. Moreover, we
found that overexpressed CD98 co-localized with Rab5a-
positive endosomes in K7721 cells, suggesting that the
sorting process was slowed or disrupted. However, trans-
fection of plasmids containing the extracellular domain
of basigin could rescue the cytoplasmic arrest of CD98.
This suggests that basigin interacts with CD98 and facili-
tates its recycling in HCC cells.
Previous reports have shown that membrane lipid
composition, such as cholesterol, can influence CD98
internalization, but not actin or dynamin [28]. Similar
results were also obtained for basigin internalization
(data not shown). Specifically, in the present study, we
found that flotillin-1, a coat component that mediates
CIE, could participate in the internalization of both basi-
gin and CD98. A previous report showed that basigin
and CD98 are internalized through Arf6-related CIE in
HeLa cells [28]. In this study, we found that both basigin
(See figure on previous page.)
Fig. 3 CD98 directly interacts with basigin in HCC cells. a Co-localization of basigin and CD98 in SMMC7721, HepG2 and Huh7 HCC cell lines. The cells
were grown on coverslips for 24 h, fixed and stained with Dylight488-conjugated goat-anti-rabbit antibodies (basigin, Green) and Dylight594-conjugated
goat-anti-mouse antibodies (CD98, Red). Huh7 cells were treated with 0.2 % Triton X-100 after fixation to visualize the intracellular distribution of basigin
and CD98. Bar, 10 μm. b CD147-ED pulls down CD98-ED in vitro. HAb18 (antibody against CD147-ED; 10 μg) was used as a coupling antibody
by immobilizing it onto the coupling resin. Then, the indicated amount of the antigen was added and eluted. The collected samples were
analyzed by western blotting. c Biophysical analysis of the interaction of CD98-ED with CD147-ED using SPR. The indicated concentrations of
purified CD98-ED were injected over immobilized CD147-ED, and the biophysical parameters were derived from a 1:1 binding model (red line).
RU, response units
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Fig. 4 CD98 is retained in the ER and Rab5 positive endosomes of live cancer cells in the absence of basigin. a Schematic of the different basigin
expression constructs and pcDNA3.1-dsRED1-CD98 (dsRED1-CD98). Note that the sequences encoding eGFP or dsRED1 were inserted into the signal
peptide and coding sequence of basigin and CD98, respectively. b Representative distribution of overexpressed CD98 (red) in SMMC7721 cells and K7721
cells. SMMC-7721 cells (5 × 104 cells) were cultured on coverslips and transfected with 2 μg of dsRED1-CD98 for 36 h. The distribution of dsRED1-CD98 was
visualized with a confocal microscope. The percentage of CD98 (red) blocked cells was determined by scoring > 100 cells. The data are the mean of the “%
of dsRED1-CD98 blocked cells” from three independent experiments ± SED. Bar, 10 μm. ** P< 0.01. c Cytoplasmic distribution of overexpressed CD98 (red)
in K7721 cells. After the transfection of dsRED1-CD98 as described in part B, the distribution of the endoplasmic reticulum (ER) was revealed with
ER-TrackerTM. Bar, 5 μm. EGFP-Rab5A Q79L or GFP-Rab11 (1 μg) was co-transfected with 1 μg of dsRED1-CD98 to visualize the endosomal distribution of
cytoplasmically retained CD98. (Pearson’s coefficient is indicated as numerical data on the right of each panel, n= 3). Bar, 10 μm. d Representative
distribution of overexpressed CD98 (red) after co-transfection of different basigin expression constructs. Three different basigin expression constructs (green)
were co-transfected with dsRED1-CD98 in K7721 cells for 36 h, and the distribution of overexpressed CD98 (red) was then visualized. Bar, 10 μm
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and CD98 are internalized through Arf6-related CIE in
HCC cells. After internalization, hook1, Rab22a and micro-
tubules could directly sort basigin and CD98 for recycling,
avoiding fusing with EEA1 (early endosome antigen-1)-
positive endosomes [10, 11]. Regardless of their
localization in vesicles or endosomes, the intracellular do-
main of CD98 and basigin are exposed to cytoplasm, and
the acidic amino acid clusters in the cytoplasmic tails of
CD98 and basigin function in the following sorting process
to tubular endosomes arranged along microtubules. The
(See figure on previous page.)
Fig. 5 Basigin facilitates the early steps of CD98 recycling. a The interaction between basigin and flotillin-1, CD98 and flotillin-1, were analyzed by
FRET imaging. Two individual dishes of SMMC-7721 cells were transfected with CD147-dsRed1 or Flotillin-1-eGFP as the acceptor and donor samples,
respectively. Two separate dishes were co-transfected with both CD147-dsRed1 and flotillin-1-eGFP as the FRET sample. Using the donor and acceptor
samples, CoA and CoB were automatically calculated with FRET software (the grey rectangle area was calculated as background). The FRET ratio is
shown on the right. b Effects of flotillin-1 knockdown on the membrane localization of basigin and CD98. SMMC-7721 cells were transfected with siRNAs
targeting flotillin-1 for 36 h, then the cells were harvested and the membrane localization of basigin and CD98 was analyzed by FACS. The knockdown
effect and total protein levels of basigin and CD98 were analyzed by western blotting. c Co-transfection of Arf6Q67L for 36 h caused the distribution of
overexpressed eGFP-N1-CD147(N) (GFP-CD147) to the vacuolar membranes in SMMC7721 cells. d Localization of CD98 in SMMC7721 cells co-expressing
GFP-CD147 and Arf6Q67L. SMMC7721 cells co-expressing GFP-CD147 and Arf6Q67L for 36 h were fixed, treated with 0.2 % Triton, and labeled with a
primary antibody to CD98 followed by Dylight594-conjugated goat-anti-mouse antibodies. Cell c was transfected with GFP-CD147 only, cell d was
transfected with GFP-CD147 and Arf6Q67L (identified by vacuolar membranes), and cells a and b were not transfected and served as a control. Bar, 10 μm
Fig. 6 General model for basigin promotes the membrane localization of CD98 and activation of β1-integrin. Basigin could facilitate the membrane
localization of newly synthesized CD98 in the ER (blue arrow). Prototypical CIE cargo proteins enter cells through Arf6-positive endocytic vesicles that either
fuse with or mature into Rab5a-positive early endosomes (sorting endosomes), where internalized proteins converge and are sorted for recycling (green
arrow) or degradation (red arrow). Basigin and CD98 are internalized by a pathway associated with flotillin-1 and the small G protein Arf6.
Thereafter, basigin and CD98 could recycle back to the membrane through the fast recycling pathway (green arrow A) mediated by hook1,
Rab22a, microtubules and their own cytoplasmic sequences. Other internalized proteins, including integrins, could recycle through the slow
recycling pathway (green arrow B). By promoting the membrane redistribution or translocation of CD98, basigin activates β1 integrins and
plays a critical role in liver cancer progression
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coincident localization between CD98 and basigin during
the internalization and recycling process, in addition to
their direct association, indicates that they are likely to be
transported together in cells. Alternative approaches,
including live-cell imaging and fluorescence resonance
energy transfer (FRET), might track the precise localization
of CD147 and CD98 in real time in the future. By binding
to each other, basigin and CD98 could use their common
sorting machinery (including SNX27 [51], hook1 and
Rab22a [10, 11]) more efficiently. Therefore, they could
recycle back to the membrane more quickly. Here, our
results showed that rapid CD98 recycling was retained in
the Rab5a-positive but not Rab11-positive endosomes, in
the absence of basigin. Internalized membrane proteins
converge in Rab5a endosomes, thereafter proteins are
sorted for degradation or recycle. Internalized lipid rafts
could recycle through Rab11-positive recycling endosomes
(slow recycling pathway) [52–54], while basigin, CD98 and
CD44 could recycle back to the membrane through the
fast recycling pathway. Here our results further confirmed
this fast recycling pathway of basigin and CD98. Mean-
while, it remains to be tested whether CD98 could influ-
ence the membrane distribution of basigin by a similar
mechanism.
Conclusions
Basigin facilitates the membrane distribution of CD98 to
promote HCC cell spreading and tumorigenicity. Our
results supported that endosome recycling emerged as
an important signaling platform, capable of controlling
the amplitude and duration of oncogenic signals. In this
process, the redistribution of CD98 and basigin by
vesicle recycling can create markedly altered phenotypes
and behaviors in HCC cells. Novel therapies towords HCC
might be carried out from the perspective of endosome
recycling.
Additional files
Additional file 1: Fig. S1. Growing SMMC-7721 cells were transfected
with pcDNA3.1-CD147 or pCMV5-CD98 for 36 h, respectively. Then cells
were collected and applied for western blotting. The data shown are
representative of three individual experiments. Fig. S2. Growing
SMMC-7721 cells were transfected with 50 mM siRNA of CD98 for
36 h. Then cells were detached for FCAS or lysied to extract RNA for
RT-PCR. Fig. S4. Western blotting was used to identify K7721 cells.
SMMC-7721 or K7721 cell lysates (30 μg) were subjected to western
blot analysis to detect basigin, CD98 and tubulin expression (reference control)
as above. The data shown are representative of three individual experiments.
(JPEG 930 kb)
Additional file 2: Fig. S3. The cDNA sequence coding the CD98-ED
(residues 111–530 of human 4F2hc) was cloned into the pET32a(+)(Invitrogen)
with Nde I and Xho I. The resulting plasmid was transformed into BL21 (DE3)
cells (Novagen), and the cells were grown in LB media at 37 °C. Cells with
A600 = 0.6 were induced with 0.1 mM isopropyl 1-thio-β-D-galactopyranoside
followed by culture for 16 h at 24 °C. Harvested cells were suspended in lysis
buffer (20 m M potassiumphosphate, pH 8.0, 500 mM NaCl, 1 mg/ml lysozyme
(RocheApplied Science), 1 mM phenylmethylsulfonyl fluoride, aprotinin,
pepstatin, andleupeptin) and lysed on a French press at 20,000 p.s.i. The
cell lysate was centrifuged twice at 12,000 g for 45 min. The soluble fraction
was applied to a His-Trap chelating 5-ml column (AmershamBiosciences Co.,
Germany), previously charged with Ni2+, in an Akta-FPLC. Eluted product was
further purified a Superdex 75 gel-filtration column. The antigen was identified
through the molecular weight and Western blot. The purification protocols of
CD147-ED as described in our previous work [33]. (JPEG 1123 kb)
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